What is the difference between a chalazion and a hordeolum in terms of causes, symptoms, and treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chalazion vs Hordeolum: Differences in Causes, Symptoms, and Treatment

A chalazion is a non-inflammatory, painless, chronic lipogranulomatous cyst resulting from blocked meibomian glands, while a hordeolum (stye) is an acute, painful bacterial infection of the eyelid margin glands that requires different treatment approaches. 1

Key Differences

Etiology and Pathophysiology

  • Chalazion:

    • Results from obstruction of meibomian glands (deep chalazion) or Zeis glands (superficial chalazion) 1
    • Non-infectious, sterile inflammatory response to retained sebaceous secretions 2
    • Often associated with meibomian gland dysfunction or posterior blepharitis 3
    • May develop following an unresolved internal hordeolum 4
  • Hordeolum:

    • Bacterial infection (commonly Staphylococcal) of eyelid glands 5
    • Internal hordeolum: affects meibomian glands deeper in the eyelid 4
    • External hordeolum (stye): affects eyelash follicles or Zeis/Moll glands at the eyelid margin 1
    • Acute inflammatory process with purulent material 6

Clinical Presentation

  • Chalazion:

    • Painless or mildly uncomfortable eyelid nodule 7
    • Develops gradually over weeks 1
    • Can occur on upper or lower eyelid 7
    • Non-erythematous unless secondarily infected 6
    • May cause localized swelling, mild discomfort, and cosmetic deformity 7
    • Can persist for months if untreated 7
  • Hordeolum:

    • Painful, erythematous, localized swelling of eyelid margin 5
    • Develops rapidly (days) 4
    • Often has a visible purulent "head" pointing toward either the conjunctival or skin surface 6
    • May be associated with eyelid edema and conjunctival injection 5
    • Typically resolves within 7-10 days with or without treatment 4

Diagnostic Approach

  • Chalazion:

    • Painless nodule within the tarsal plate 1
    • Visible meibomian gland obstruction on eyelid eversion 3
    • History of gradual onset 7
    • May be associated with history of blepharitis or meibomian gland dysfunction 3
  • Hordeolum:

    • Painful, erythematous nodule at eyelid margin 5
    • Rapid onset with signs of acute inflammation 4
    • May have purulent discharge 6
    • Often associated with bacterial blepharitis 3

Treatment Approaches

Chalazion Management

  • Conservative treatment (first-line):

    • Warm compresses (10-15 minutes, 3-4 times daily) to liquefy the thickened secretions 2
    • Eyelid massage to express the obstructed gland contents 3
    • Eyelid hygiene to address underlying blepharitis or meibomian gland dysfunction 7
    • May resolve spontaneously over several weeks to months 7
  • Medical interventions:

    • Topical antibiotics (with or without steroids) may help if secondary infection is present 2
    • Intralesional steroid injection (triamcinolone acetonide) for persistent chalazia 2
  • Surgical intervention:

    • Indicated for persistent chalazia (>2 months) or those causing significant symptoms 2
    • Incision and curettage under local anesthesia 2
    • Consider biopsy for recurrent chalazia in the same location or atypical presentations to rule out sebaceous carcinoma 7

Hordeolum Management

  • Conservative treatment:

    • Warm compresses (10-15 minutes, 4-6 times daily) to promote drainage 4
    • Avoid squeezing or manipulating the lesion 5
    • Most resolve spontaneously within 7-10 days 4
  • Medical interventions:

    • Topical antibiotics (e.g., bacitracin, erythromycin) if spreading infection is suspected 5
    • Oral antibiotics rarely needed unless cellulitis develops 4
  • Surgical intervention:

    • Incision and drainage may be considered for persistent, painful hordeola that don't drain spontaneously 5

Important Clinical Considerations

  • Warning signs requiring further evaluation:

    • Recurrent chalazia in the same location (consider sebaceous carcinoma) 7
    • Unilateral chronic blepharitis unresponsive to therapy (consider carcinoma) 3
    • Loss of eyelashes (madarosis) in the affected area 3
    • Atypical clinical appearance or progression 6
  • Special populations:

    • Children with chalazia may have underlying chronic blepharokeratoconjunctivitis requiring evaluation by an ophthalmologist 7
    • Patients with recurrent chalazia should be evaluated for underlying conditions like meibomian gland dysfunction, rosacea, or seborrheic dermatitis 3
  • Prevention strategies:

    • Regular eyelid hygiene for patients with blepharitis or meibomian gland dysfunction 3
    • Treatment of underlying skin conditions (rosacea, seborrheic dermatitis) 3
    • Avoiding eye makeup during active inflammation 3

References

Research

The lowly chalazion.

Survey of ophthalmology, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Non-surgical interventions for acute internal hordeolum.

The Cochrane database of systematic reviews, 2017

Research

Interventions for acute internal hordeolum.

The Cochrane database of systematic reviews, 2013

Research

[Hordeolum and chalazion : (Differential) diagnosis and treatment].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2022

Guideline

Chalazion Characteristics and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.